Product Information
ACID REDUCER 20 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.1382 per EA under NDC 49483072001. Its NADAC has been published 113 times since Aug 7, 2024.
FDA first approved this application on Mar 8, 2023.
Strength
20 mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483072001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA217543FDA Approved
3/8/2023
On Market Since
6/15/2023
Pharmacological Classes
Price Statistics
The NADAC for ACID REDUCER 20 MG TABLET has been published 113 times since Aug 7, 2024, and over the history we have for it it has declined 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1382 per EA |
|---|---|
| All-time high | $0.1487 (Jun 11, 2025) |
| All-time low | $0.1365 (Aug 21, 2024) |
| 52-week high | $0.1480 |
| 52-week low | $0.1382 |
| Median price | $0.1440 |
| Average price | $0.1436 |
| Largest weekly change | -6.2% (Aug 21, 2024) |
| Weeks tracked | 113 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 24 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 79% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Time-Cap Labs Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACID REDUCER 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACID REDUCER 20 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.1382 per EA (NDC 49483072001), effective Sep 30, 2026.
How has the price of ACID REDUCER 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACID REDUCER 20 MG TABLET has declined 5.1%. It has been tracked across 113 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for ACID REDUCER 20 MG TABLET?
Since Aug 7, 2024, the NADAC for ACID REDUCER 20 MG TABLET has ranged from a low of $0.1365 (Aug 21, 2024) to a high of $0.1487 (Jun 11, 2025), with a median of $0.1440 per EA.
Are there cheaper alternatives to ACID REDUCER 20 MG TABLET?
Yes. 24 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FAMOTIDINE 20 MG TABLET, is $0.0289 per EA — about 79% below ACID REDUCER 20 MG TABLET.
Who manufactures ACID REDUCER 20 MG TABLET?
ACID REDUCER 20 MG TABLET (NDC 49483072001) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.